Basit öğe kaydını göster

Analysis of Social Class by LCA in Patients with Schizophrenia: Change in Psychopathology after 12 Month of Treatment

dc.contributor.authorUcok, Alp
dc.contributor.authorSaylan, Mete
dc.contributor.authorUguz, Suekrue
dc.contributor.authorTreuer, Tamas
dc.contributor.authorSir, Aytekin
dc.date.accessioned2021-03-05T16:01:43Z
dc.date.available2021-03-05T16:01:43Z
dc.date.issued2009
dc.identifier.citationSaylan M., Ucok A., Uguz S., Treuer T., Sir A., "Analysis of Social Class by LCA in Patients with Schizophrenia: Change in Psychopathology after 12 Month of Treatment", KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.19, ss.29-38, 2009
dc.identifier.issn1017-7833
dc.identifier.othervv_1032021
dc.identifier.otherav_beb0cb0c-5474-4024-96cd-f8b3331ae924
dc.identifier.urihttp://hdl.handle.net/20.500.12627/126629
dc.description.abstractObjective: The social factors may contribute to the heterogeneous course of schizophrenia and relationship between these factors and the level of care received is complex. Social factors may influence access to treatment and outcome of the disease. Current diagnostic systems classify longitudinal course of schizophrenia based on symptom patterns. We aimed to identify latent social classes in Turkish patients with schizophrenia who participated to IC-SOHO observational study. Latent class analysis may allow a physician to understand various patient social groups (social casemix) in a very heterogeneous patient data flow seen in everyday practice.
dc.language.isoeng
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPsikiyatri
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.titleAnalysis of Social Class by LCA in Patients with Schizophrenia: Change in Psychopathology after 12 Month of Treatment
dc.typeMakale
dc.relation.journalKLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
dc.contributor.departmentAbbott Labs , ,
dc.identifier.volume19
dc.identifier.issue1
dc.identifier.startpage29
dc.identifier.endpage38
dc.contributor.firstauthorID191795


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster